Welcome

BioPharmica Ltd manages a strong portfolio of biomedical technologies emerging from research by leading Universities, Medical Institutes and Hospitals across Australia. The company provides product development and commercial direction, whilst the institutional partner provides the majority of the infrastructure and research expertise.
Technologies on the way to commercialization include diagnosis of infectious disease, brain function monitoring, pre-clinical molecules for use in oncology, metabolic, neurodegenerative, infectious disease, and nanoprobe technology.

Download BioPharmica Annual Report 2008
BioPharmica Annual Report 2008


Email Subscription


Enter your email address below to recieve our email updates



Latest News

Alison Mees
Published on November 30, 2007 1:28 PM

Winner of the 2007 Department of Industry and Resources Science and Innovation Studentship Award (SISA)

BioPharmica Limited takes great pleasure in congratulating Alison Mees on her success in winning a 2007 Department of Industry & Resources Studentship Award. The studentship award will see Alison test novel compounds for anti-cancer properties.

News Archives



ASX LOGO